Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 13, Issue 3 (2024)

Screening of antiaflatoxin, anti-inflammatory performance and biosafety of Spondias mombi Linn. (Hog Plum) leaf extract

Author(s):
Banso A, Dachi S, Ajewole AE, NMA ETSU-MUSA and Ajayi MA
Abstract:
Spondia mombi belonging to the Anacardiaceae family has demonstrated efficacy in treating inflammatory conditions, wounds, and infections. Found commonly in Africa, Americas and Asia, its leaf extract was tested for their antiaflatoxin, anti-inflammatory and biosafety properties. A thin layer chromatographic (TLC) technique was employed to assess aflatoxin levels in Aspergillus flavus, Aspergillus versicolor and Fusarium oxysporum. The inhibition of aflatoxin increased with higher concentrations of Spondia mombi leaf extract, with aflatoxin B1 being completely inhibited at 300mg/ml concentration. Additionally, the plant extract showed significant protection against hemolysis, particularly at higher concentrations and no hemolysis was observed in the absence of aflatoxin. This study highlights the potent antiaflatoxin, anti-inflammatory and biosafety of properties of Spondia mombi leaf extract, suggesting potential for further exploration of plant-based remedies for various medical conditions.
Pages: 189-192  |  82 Views  46 Downloads


The Pharma Innovation Journal
How to cite this article:
Banso A, Dachi S, Ajewole AE, NMA ETSU-MUSA, Ajayi MA. Screening of antiaflatoxin, anti-inflammatory performance and biosafety of Spondias mombi Linn. (Hog Plum) leaf extract. Pharma Innovation 2024;13(3):189-192.

Call for book chapter